APA (7th ed.) Citation

Fang, L., Radovits, T., Szabó, G., Mózes, M. M., Rosivall, L., & Kökény, G. (2013). Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes. Nephrology, dialysis, transplantation, 28(7), . https://doi.org/10.1093/ndt/gfs391

Chicago Style (17th ed.) Citation

Fang, Lilla, Tamás Radovits, Gábor Szabó, Miklós M. Mózes, László Rosivall, and Gábor Kökény. "Selective Phosphodiesterase-5 (PDE-5) Inhibitor Vardenafil Ameliorates Renal Damage in Type 1 Diabetic Rats by Restoring Cyclic 3′,5′ Guanosine Monophosphate (cGMP) Level in Podocytes." Nephrology, Dialysis, Transplantation 28, no. 7 (2013). https://doi.org/10.1093/ndt/gfs391.

MLA (9th ed.) Citation

Fang, Lilla, et al. "Selective Phosphodiesterase-5 (PDE-5) Inhibitor Vardenafil Ameliorates Renal Damage in Type 1 Diabetic Rats by Restoring Cyclic 3′,5′ Guanosine Monophosphate (cGMP) Level in Podocytes." Nephrology, Dialysis, Transplantation, vol. 28, no. 7, 2013, https://doi.org/10.1093/ndt/gfs391.